论文部分内容阅读
骨质疏松是以骨量减少,骨脆性增加,骨折危险性增高为表现的全身骨代谢障碍疾病。女性骨质疏松比男性多5倍,已被视为是一种妇女病。胎儿期、婴儿期和青春期是人体骨骼生长发育最重要时期。骨质疏松症被称为“具有老年期影响的儿科疾病”[1]。女性在18岁时约完成90%的骨矿积累,骨量在30~40岁达峰值[2]。几乎所有女性都会经历渐进性的骨质丢失,尤其是更年期开始至绝经后,骨质丢失加速,引起骨小梁变薄和断裂。药物治疗能阻止骨质的
Osteoporosis is a systemic bone metabolism disorder characterized by decreased bone mass, increased bone fragility and increased risk of fracture. Osteoporosis in women is five times more common than in men and is considered a woman’s disease. Fetus, infancy and adolescence are the most important periods of human bone growth and development. Osteoporosis is called “pediatric disease with age-related effects” [1]. About 18% of women complete bone mineral accumulation at the age of 18, the peak of bone mass in 30 to 40 years [2]. Almost all women experience gradual loss of bone mass, especially after menopause begins to the menopause, bone loss accelerates, causing trabecular thinning and fracture. Medication can stop the bone